AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21302138
Drug: Rabeprazole 5
RxNorm normalized name: RABEprazole 5 mg oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 5 mg/day
Trial: 19703730
Drug: Topical ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketamine (10% cream) applied to the symptomatic limb
Trial: 17983368
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol plus bisacodyl tablets
Trial: 11725734
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (transcervical Foley balloon + intravaginal misoprostol)
Trial: 3126515
Drug: Ethanol (0.695
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.695 g/kg of body weight over a 15‐min period)
Trial: 31586424
Drug: Caspofungin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caspofungin (2 mg/kg once daily)
Trial: 31586424
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B deoxycholate (1 mg/kg)
Trial: 22946775
Drug: i-Gel(TM)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-Gel(TM)
Trial: 21191437
Drug: Web-based LFQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based LFQ administration
Trial: 21191437
Drug: Interactive voice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive voice response system (IVRS)-based LFQ administration
Trial: 21191437
Drug: Interviewer-based LFQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-based LFQ administration
Trial: 21191437
Drug: Paper-based LFQ
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-based LFQ administration
Trial: 33053
Drug: Terfenadine 60,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 60, 120 and 240 mg
Trial: 26303801
Drug: Elbasvir (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elbasvir (5 to 50 mg for genotype 1; 10 to 100 mg for genotype 3) once daily for 5 days
Trial: 14742331
Drug: Caudal ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal ketamine group (bupivacaine + S(+)-ketamine 0.5 mg x kg(‐1))
Trial: 14742331
Drug: i.v. ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. ketamine group (bupivacaine + S(+)-ketamine 0.5 mg x kg(‐1) i.v.)
Trial: 14742331
Drug: Bupivacaine group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine group (plain bupivacaine 0.25% 1 ml x kg(‐1))
Trial: 3884688
Drug: 100 mcg
RxNorm normalized name: Levo-T 100 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mcg of albuterol powder
Trial: 3884688
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg of albuterol powder
Trial: 3884688
Drug: 400 mcg
RxNorm normalized name: Biotin 400 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mcg of albuterol powder
Trial: 28286262
Drug: IV magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV magnesium sulfate (100 mg/kg)
Trial: 11117082
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of right‐to‐left chamber disproportion with CNS, NSF, HB and PY
Trial: 8645387
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (1 mg/kg/day in three divided doses)
Trial: 1464342
Drug: Ubiquinone (coenzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ubiquinone (coenzyme Q10) 3 x 33.3 mg/day orally for 4 months
Trial: 2982622
Drug: 1 g/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/m2 of cyclophosphamide pretreatment before chemotherapy
Trial: 2982622
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (cyclophosphamide, vincristine, and methotrexate) without pretreatment
Trial: 27575409
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab monotherapy (IVM)
Trial: 27575409
Drug: Intravitreal combination
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal combination (IVC) of dexamethasone implant and ranibizumab
Trial: 26226350
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nicotine and moclobemide
Trial: 24183037
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus clopidogrel (75 mg clopidogrel + 100 mg aspirin daily)
Trial: 24183037
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (100 mg daily)
Trial: 12584669
Drug: Candesartan treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan treatment
Trial: 17211970
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine + 120 mg ketorolac + saline solution up to 96 ml with an elastomeric pump i.v.
Trial: 10980174
Drug: Ofloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin 400 mg once daily for 5 days
Trial: 10980174
Drug: Ofloxacin therapy
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin therapy for 3 days
Trial: 10385641
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) treatment for 2 years
Trial: 6233547
Drug: Inhaling a
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaling a combined preparation of fenoterol 200 micrograms and ipratropium bromide 80 micrograms (Duovent)
Trial: 6233547
Drug: Inhaling a
RxNorm normalized name: Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaling a similar dose of fenoterol
Trial: 12735531
Drug: Leisure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leisure therapy
Trial: 9673264
Drug: Acellular vaccine
RxNorm normalized name: PERTUSSIS VACCINE,ACELLULAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular vaccine containing pertussis toxin (PT), filamentous hemagglutinin (FHA), and pertactin (PRN)
Trial: 18850516
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (25 microg initial dose, followed by 50 microg doses at 3-6 hour intervals)
Trial: 18850516
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter and oral misoprostol (100 microg at 4-6 hour intervals)
Trial: 18850516
Drug: Foley catheter
RxNorm normalized name: Bard Foley Catheter 18FR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Foley catheter and oral misoprostol
Trial: 18850516
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol and Foley catheter with oral misoprostol
Trial: 14763920
Drug: Transdermal oestradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal oestradiol plus CPA (n=12)
Trial: 9164314
Drug: Lamivudine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (150 mg twice a day)
Trial: 9164314
Drug: Lamivudine plus
RxNorm normalized name: Lamivudine
DrugBank: Lamivudine (DB00709)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lamivudine plus Loviride (150 mg twice a day plus 100 mg three times a day)
Trial: 7696153
Drug: Automated image
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Automated image analysis for estrogen receptor (ER) content
Trial: 7696153
Drug: Automated image
RxNorm normalized name: triclosan
DrugBank: Triclosan (DB08604)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Automated image analysis for progesterone receptor (PR) content
Trial: 3427825
Drug: Keyhole limpet
RxNorm normalized name: Keyhole limpet hemocyanin
DrugBank: Keyhole limpet hemocyanin (DB05299)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Keyhole limpet haemocyanin (KLH) 2.5 mg
Trial: 3427825
Drug: Rabies vaccine
RxNorm normalized name: RABIES VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabies vaccine (RV) 170 micrograms
Trial: 3427825
Drug: Rabies vaccine
RxNorm normalized name: RABIES VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabies vaccine (RV) 680 micrograms
Trial: 12950410
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg levofloxacin once a day over 10 days
Trial: 8091868
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg methotrexate (MTX) per week
Trial: 8091868
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg methotrexate (MTX) per week
Trial: 2855325
Drug: Sequential chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential chemotherapy using three different drug-combinations
Trial: 27665002
Drug: Scattered-site Housing
RxNorm normalized name: SOLO SITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scattered-site Housing First (SHF) with Assertive Community Treatment
Trial: 25725780
Drug: TAP block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP block with 20 ml 0.25 % levobupivacaine (100 mg)
Trial: 21483384
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg physostigmine in 250 mL N/S 0.9% (Physo group)
Trial: 21483384
Drug: 250 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL N/S 0.9% placebo (Control group)
Trial: 18155759
Drug: Adaper Prompt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaper Prompt L‐Pop (PLP)
Trial: 15107914
Drug: Non-fluoridated dentifrice
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fluoridated dentifrice with 20% sucrose solution dripped 10 times a day
Trial: 10688723
Drug: Narrow-band UVB
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-band UVB phototherapy combined with topical tazarotene 0.05% applied once daily
Trial: 10688723
Drug: Narrow-band UVB
RxNorm normalized name: Band-Aid Hurt-Free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Narrow-band UVB phototherapy (monotherapy)
Trial: 2394301
Drug: Fumaric acid
RxNorm normalized name: Fumaric Acid
DrugBank: Fumaric acid (DB01677)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fumaric acid combination (FAC-EC)
Trial: 28905478
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg every 2 weeks, with potential increase to 150 mg every 2 weeks at week 12 if LDL cholesterol levels were ≥1.8 mmol/L at week 8.
Trial: 25783974
Drug: Everolimus with
RxNorm normalized name: Everolimus
DrugBank: Everolimus (DB01590)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Everolimus with complete calcineurin inhibitor elimination
Trial: 20671295
Drug: Intranasal d-amphetamine
RxNorm normalized name: amphetamine / dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal d-amphetamine (0, 16, 24, and 32 mg/70 kg)
Trial: 20671295
Drug: Oral d-amphetamine
RxNorm normalized name: amphetamine / dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral d-amphetamine (equal doses to intranasal)
Trial: 10181019
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of outcome information and self-efficacy enhancing information
Trial: 7589026
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg controlled-release metoprolol
Trial: 21784729
Drug: golimumab 100
RxNorm normalized name: golimumab 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: golimumab 100 mg plus placebo
Trial: 21784729
Drug: golimumab 50
RxNorm normalized name: GOLIMUMAB 50MG/0.5ML INJ SYRINGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: golimumab 50 mg plus placebo
Trial: 16944674
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of zolpidem (Z)
Trial: 15351162
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil introduction with cyclosporine reduction (target trough levels 2-4 microg/ml)
Trial: 8441139
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide 60 mg intramuscularly
Trial: 21190800
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment (single implants on two occasions in summer, n=1399)
Trial: 21190800
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment (n=1399)
Trial: 21190800
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment in Herd A (n=1399)
Trial: 21190800
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment at 60kg live-weight in Year 1
Trial: 21190800
Drug: Melatonin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin treatment in Herd B (n=1399)
Trial: 14754784
Drug: Continuous sertraline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous sertraline (50-100 mg/day)
Trial: 14754784
Drug: Intermittent sertraline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent sertraline (50-100 mg/day)
Trial: 11553257
Drug: Tropisetron 5
RxNorm normalized name: tropisetron 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tropisetron 5 mg with metoclopramide 5 mg
Trial: 352184
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg intravenously
Trial: 7946181
Drug: Isradipine monotherapy
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine monotherapy (4.55 +/- 0.56 mg twice daily)
Trial: 7946181
Drug: Isradipine plus
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine plus bopindolol (7.5 +/- 0.63 mg twice daily and 1.16 +/- 0.12 mg once daily)
Trial: 7946181
Drug: Isradipine monotherapy
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine monotherapy and Isradipine plus bopindolol
Trial: 3041824
Drug: Once-daily evening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily evening doses of controlled-release theophylline (Uniphyl tablets)
Trial: 7433519
Drug: Mianserin 30-80
RxNorm normalized name: mianserin 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin 30-80 mg daily
Trial: 7433519
Drug: Diazepam 15-40
RxNorm normalized name: diazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 15-40 mg daily
Trial: 28667408
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of S-1 at a standard dose of 80 mg/m2/day
Trial: 28667408
Drug: Alternate-day administration
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day administration of S-1 on 4 days a week
Trial: 28667408
Drug: Daily administration
RxNorm normalized name: Prevpac 30mg-500mg-500mg Daily Administration Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily administration of S-1
Trial: 28667408
Drug: Alternate-day administration
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day administration of S-1
Trial: 17508038
Drug: Neuroprotective drug
RxNorm normalized name: NEUROPROTECTIN D1
DrugBank: AP-001 (DB18511)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroprotective drug
Trial: 15600246
Drug: Peru-15 (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peru-15 (recombinant cholera vaccine)
Trial: 8109763
Drug: Ondansetron 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 0.15 mg/kg (maximum = 8 mg)
Trial: 3396118
Drug: Fosfomycin 8
RxNorm normalized name: FOSFOMYCIN
DrugBank: Fosfomycin (DB00828)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fosfomycin 8 g b.i.d.
Trial: 3396118
Drug: Ampicillin 2
RxNorm normalized name: ampicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 2 g t.i.d.
Trial: 5781487
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (40 to 80 mg daily for 17 months)
Trial: 5781487
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (40 to 80 mg daily for 9 months)
Trial: 22804755
Drug: Melatonin 10
RxNorm normalized name: melatonin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 10 mg/day for 28 days
Trial: 21709648
Drug: Modified triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified triple loop corrector (appliance therapy)
Trial: 21709648
Drug: Positive reinforcement
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive reinforcement (reward therapy)
Trial: 18651343
Drug: Venlafaxine 37.5
RxNorm normalized name: venlafaxine 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 37.5 mg b.i.d. for 7 days followed by 75 mg b.i.d. for another 7 days
Trial: 17961403
Drug: Fixed dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dosage of ICS (fluticasone) plus LABA (salmeterol) maintained for 18 months in group A
Trial: 17961403
Drug: Tailored dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored dosage or withdrawal of therapy according to clinical control in group B
Trial: 17961403
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with ICS plus LABA
Trial: 17961403
Drug: Adjustment of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjustment of therapy based on clinical parameters in group B
Trial: 17961403
Drug: PC(35) sGaw
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC(35) sGaw monitoring in therapy adjustment
Trial: 15336593
Drug: HRT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT group (n = 146) received a sequential combination of 2 mg estradiol valerate and 1 mg cyproterone acetate and calcium lactate, 500 mg/day (equal to 93 mg Ca2+) alone or in combination with vitamin D3, 100‐300 IU/day.
Trial: 15336593
Drug: non-HRT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: non-HRT group (n = 170) received calcium lactate, 500 mg alone or in combination with vitamin D3, 100‐300 IU/day.
Trial: 2455148
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg nifedipine tablet
Trial: 2455148
Drug: 2 X
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 X 10 mg nifedipine capsules
Trial: 28739794
Drug: AZD-5847 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD-5847 (500 mg once daily)
Trial: 28739794
Drug: AZD-5847 (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD-5847 (1,200 mg once daily)
Trial: 28739794
Drug: AZD-5847 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD-5847 (500 mg twice daily)
Trial: 28739794
Drug: AZD-5847 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD-5847 (800 mg twice daily)
Trial: 26276704
Drug: Standard Family-Based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Family-Based Treatment (FBT)
Trial: 23695207
Drug: Low-fat vegan
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat vegan diet with weekly group support and work cafeteria options for 18 weeks
Trial: 21145112
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help (Problem Solving Treatment and exposure) for 6 weeks
Trial: 10889113
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (14.4 Gy, 1.8 Gy per day, five fractions per week)